The increased reimbursement makes out product more competitive as doctors receive a larger rebate so increases the likeliness of surgeons recommending/using our technology and thus will should lead to a significant increase in sales
- Forums
- ASX - By Stock
- EYE
- Ann: Full Year Financial Results
Ann: Full Year Financial Results, page-44
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $53.82M |
Open | High | Low | Value | Volume |
24.5¢ | 25.0¢ | 22.0¢ | $231.2K | 989.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 95244 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 70000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 92800 | 0.225 |
9 | 254531 | 0.220 |
2 | 120000 | 0.215 |
5 | 196683 | 0.210 |
4 | 96803 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 70000 | 2 |
0.240 | 136000 | 3 |
0.245 | 22222 | 1 |
0.250 | 212888 | 4 |
0.255 | 20000 | 1 |
Last trade - 14.54pm 26/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |